Home › Acute Myeloid Leukemia › North Carolina › Charlotte

Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Charlotte, NC

16 pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Charlotte (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Novant Health Presbyterian Medical Center, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Novant Health Presbyterian Medical Center, Charlotte

Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Nagre-recruitPhase 3

Atrium Health, Charlotte
Novant Health Charlotte, Charlotte
Carolina Oncology Specialists, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Carolinas Medical Center/Levine Cancer Institute, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Carolinas Medical Center/Levine Cancer Institute, Charlotte

Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Carolinas Medical Center/Levine Cancer Institute, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Nagre-recruitPhase 3

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Novant Health Presbyterian Medical Center, Charlotte

6 Months – 21 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Nagre-recruitPhase 2

Novant Health Clinical Research, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06824168

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Nagre-recruitObservasyonal na pag-aaral

Novant Health Weisiger Cancer Institute, Charlotte

Edad 0 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07154823

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Nagre-recruitPhase 1/2

Carolinas Medical Center/Levine Cancer Institute, Charlotte
Novant Health Presbyterian Medical Center, Charlotte

Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

Nagre-recruitPhase 1

Carolinas Medical Center/Levine Cancer Institute, Charlotte

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05886049

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Atrium Health Levine Cancer Center, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML

Nagre-recruitObservasyonal na pag-aaral

Levine Cancer Institute, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06580106

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

Nagre-recruit

Levine Cancer Insitute, Charlotte

Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06945042

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Levine Children's Hospital, Charlotte

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS

Nagre-recruitPhase 1/2

Novant Health Cancer Institute, Charlotte

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT06680752

Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Charlotte

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.